Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000688023 | SCV000815619 | uncertain significance | Atrial standstill 1; Atrial fibrillation, familial, 11 | 2024-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu145Serfs*14) in the GJA5 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 214 amino acid(s) of the GJA5 protein. This variant is present in population databases (rs781802553, gnomAD 0.004%). This premature translational stop signal has been observed in individual(s) with atrial fibrillation (PMID: 34495297). ClinVar contains an entry for this variant (Variation ID: 567837). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001756167 | SCV002007206 | uncertain significance | not provided | 2022-10-07 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Frameshift variant predicted to result in protein truncation as the last 214 amino acids are lost and replaced with 13 incorrect amino acids, although only one downstream loss-of-function variant has been reported in HGMD and loss-of-function is not an established mechanism of disease (HGMD); Not observed at significant frequency in large population cohorts (gnomAD) |